Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VENTURE-PHH
NCT07662174Phase 2Not yet recruiting
- Sponsor
- Massachusetts General Hospital
- Start
- Jan 2027
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 2 trial of sirolimus in Post-hemorrhagic Hydrocephalus (PHH), sponsored by Massachusetts General Hospital. Planned start Jan 2027; status: not yet recruiting.
02
Drugs
sirolimus
03
Conditions
Post-hemorrhagic Hydrocephalus (PHH)
Beyond the preview
Go deeper on NCT07662174.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07662174.